BioCanRx, and partners, announce funding to manufacture first made-in-Canada CAR-T cells
BioCanRx announces funding for 16 collaborative research projects on novel therapies to cure cancer, including CAR-T cell therapy development in Canada. The investment will enable Canadian researchers to develop expertise and capacity required to deliver this technology.